EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

13q Deletion Syndrome Presenting with Lymphopenia Detected Through Newborn Screening for Primary Immunodeficiencies

Irina Efimova iD, Anna Mukhina, Zhanna Markova iD, Sergey Mordanov, Irina Soprunova, Dmitry Pershin iD, Natalya Balinova iD, Yunna Petrusenko iD, Dmitry Meleshko, Rena Zinchenko iD, Nadezhda Shilova iD, Sergey Voronin und 3 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199302 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Irina Efimova und 14 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Medical Genetics, Moscow 115522, Russia. Hauptthemen laut MEDLINE: Lymphopenia, Chromosome Disorders, Primary Immunodeficiency Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The expanded newborn screening (NBS) program in the Russian Federation, launched in 2023, includes the detection of severe forms of T- and B-cell immunodeficiencies via TREC/KREC quantification. We report a rare case of a male infant having multiple congenital anomalies and lymphopenia identified through this program. Genetic testing revealed a 25.8 Mb terminal deletion spanning 13q31.2–qter, consistent with 13q deletion syndrome. Initial NBS revealed reduced TREC levels, prompting further evaluation. The patient exhibited a complex phenotype, including central nervous system malformation (alobar holoprosencephaly), severe congenital heart disease, renal hypoplasia, limb and genitourinary anomalies, and facial dysmorphism. Postnatal complications included pneumonia, pleuritis, and chylothorax. Flow cytometry demonstrated mild T- and B-cell lymphopenia. The genomic defect was characterized using long-read third-generation sequencing, enabling precise breakpoint identification and accurate mapping of deleted genes. The deletion was confirmed via subtelomeric FISH analysis. The patient died at 7 months of age due to the progression of underlying congenital anomalies and associated complications. Our findings broaden the clinical characterization of distal 13q deletion syndrome and demonstrate the value of long-read sequencing in structural chromosomal analysis. They further highlight the difficulties of caring for neonates having complex malformations and immune dysfunction. Given the potential for both primary and secondary immune disturbances, comprehensive immunological evaluation should be considered in patients having 13q deletion syndrome to improve diagnostic accuracy and inform appropriate clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphopeniaChromosome DisordersPrimary Immunodeficiency DiseasesHumansInfant, NewbornMaleChromosome DeletionChromosomes, Human, Pair 13Neonatal ScreeningInfant

Stichwörter der Autor:innen

13q deletion syndromeTREC/KREC assaylong-read sequencingnewborn screeningprimary immunodeficiency

Autor:innen und Institutionen

  • Research Centre for Medical Genetics, Moscow 115522, Russia.
  • Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, Moscow 117198, Russia.
  • Medical Genetics Laboratory, Rostov State Medical University, Rostov-on-Don 344022, Russia.
  • Center for Family Health and Reproduction, Astrakhan 414040, Russia.
  • "Biotech Campus" LLC, Moscow 117437, Russia.
  • Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia.

ORCID-Profile: Irina Efimova, Zhanna Markova, Dmitry Pershin, Natalya Balinova, Yunna Petrusenko, Rena Zinchenko, Nadezhda Shilova, Andrey Marakhonov

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Efimova, I., Mukhina, A., Markova, Z., Mordanov, S., Soprunova, I., Pershin, D., Balinova, N., Petrusenko, Y., Meleshko, D., Zinchenko, R., Shilova, N., Voronin, S., Shcherbina, A., Kutsev, S., & Marakhonov, A. (2025). 13q Deletion Syndrome Presenting with Lymphopenia Detected Through Newborn Screening for Primary Immunodeficiencies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199302

Vancouver

Efimova I, Mukhina A, Markova Z, Mordanov S, Soprunova I, Pershin D, et al. 13q Deletion Syndrome Presenting with Lymphopenia Detected Through Newborn Screening for Primary Immunodeficiencies. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199302

BibTeX
@article{Efimova2025,
  author = {Efimova, Irina and Mukhina, Anna and Markova, Zhanna and Mordanov, Sergey and Soprunova, Irina and Pershin, Dmitry and Balinova, Natalya and Petrusenko, Yunna and Meleshko, Dmitry and Zinchenko, Rena and Shilova, Nadezhda and Voronin, Sergey and Shcherbina, Anna and Kutsev, Sergey and Marakhonov, Andrey},
  title = {13q Deletion Syndrome Presenting with Lymphopenia Detected Through Newborn Screening for Primary Immunodeficiencies},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199302}
}
Kostenlos starten →